Zealand Pharma

Boehringer Ingelheim booth at AACR 2026
Biotech

Zealand slides as Boehringer-partnered obesity drug underwhelms

With the readout echoing earlier data that underwhelmed analysts, shares in Boehringer’s partner Zealand Pharma fell 12% in early trading in Denmark.
Nick Paul Taylor Oct 1, 2026 6:15am
obesity overweight weight loss weigh

Roche, Zealand see phase 2 amylin weight loss peak at mid-dose

Sep 30, 2026 4:57am
dollar sign pipeline

Zealand sells rights to Takeda’s blood cancer drug for $100M

Aug 13, 2026 5:05am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Biogen R&D vet gets in Formation—Chutes & Ladders

Jul 24, 2026 8:30am
New Orleans
Favicon Fierce Pharma

Eli Lilly is the ‘clear winner’ from ADA, RBC analyst says

Jun 8, 2026 3:12pm
Boehringer Ingelheim ADA2026 BI

ADA: Tolerability questions linger for Boehringer's obesity drug

Jun 8, 2026 4:30am